The new funds bolster Direxion's existing single-stock ETF lineup, which now has just over 50 ETFs. These funds are ideal for traders looking to add additional exposure to a company's stock without the use of a margin account. Additionally, where applicable, they provide inverse exposure for a tactical hedge or a standalone short trade. Direxion continues to expand its single-stock ETF offerings for tactical traders. It has introduced five new single stock funds that add exposure to Oracle, Coinbase, Robinh ...

Core Insights - The healthcare sector is showing potential signs of recovery after a period of underperformance, particularly as large-cap momentum stocks have overshadowed it [1][4] - Despite previous bullish trends during the pandemic, the sector faced challenges due to regulatory scrutiny and rising costs, leading to a decline in investor interest [2][3] - Recent stock performances of major healthcare companies like UnitedHealth Group, HCA Healthcare, and CVS Health Corp indicate a possible early rally in the sector [4] Market Performance - The S&P 600 Health Care Sector has been lagging behind the broader S&P 500 and S&P 600 indices, reflecting ongoing challenges within the sector [3] - The potential for a sustained rally in the healthcare sector remains uncertain, prompting tactical traders to consider leveraged ETFs like the Direxion Daily Healthcare Bull 3X ETF (CURE) for increased exposure [4] ETF and Holdings - The CURE ETF offers 300% exposure to the Health Care Select Sector Index, providing broad coverage of the healthcare sector without the concentration risk associated with individual stocks [4] - Key holdings in the CURE ETF include major companies such as Lilly, Johnson & Johnson, and Abbvie, representing various industries within the healthcare sector [5]